1. Major bleeding risk during anticoagulation with Warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation;Adeboyeje;J. Manag. Care Spec. Pharm.,2017
2. Screening of Mucor spp. for the production of amylase, lipase, polygalacturonase and protease;Alves;Braz. J. Microbiol.,2002
3. Detection of extracellular protease in Mucor species;Alves;Rev. Iberoam. De. Micol.,2005
4. Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures;Andrade,2018
5. Mecanismos de hepatotoxicidade Mechanisms of hepatotoxicity;Bertolami;Arq. Bras. Cardiol.,2005